South Korea NSCLC Therapeutics Market Analysis


  • Type: Oncology area
  • Published : June 2021
  • Region: Asia
  • Country: South Korea
  • Report ID : 4963

  • Format: PPT, PDF

South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market: Segmented By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy) and By Drug Class (Angiogenesis Inhibitors, Kinase Inhibitors, Epidermal Growth Factor Receptor Blockers, Microtubule Stabilizers, PD-1/PD-L1 Inhibitors, and Folate Antagonists) – Growth, Trends and Forecasts (2020 – 2028)

SKU: 4963 Categories: ,

Report Overview

The South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics market size stood at around USD 136 million in 2020 and is projected to reach xx million by 2028, exhibiting a CAGR of around xx% during the forecast period.

Lung cancer is divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC metastasizes to other organs slower in comparison to SCLC, and microscopically, SCLC is composed of much smaller cells. If untreated, SCLC can be fatal in a few weeks, in contrast to most cases of NSCLC. Approximately 85 % of lung cancer patients in South Korea are affected with non-small cell lung cancer (NSCLC), creating a plethora of opportunities for pharmaceutical companies to expand their portfolios of drugs for this disease.

In 2020, South Korea’s NSCLC market experienced a 15% increase compared to the previous year, and the average annual growth rate for the past three years has been 18%.

Market Drivers

South Korea reported 28,651 new cases of Lung Cancer in 2020 and more than 80% of the reported cases were of NSCLC, increasing burden of the disease is a major factor driving the NSCLC market. South Korea’s aging population presents drug manufacturers with a vast market, as patients are generally aged 65 or above at the time of diagnosis. In addition to this, the majority of patients are in stage III or IV at the time of diagnosis, where the primary treatment involves drugs. The US Food and Drug Administration (FDA) is implementing an accelerated approval system that shortens clinical trials for serious diseases, this will further propel the market growth.

Pharmaceutical company’s’ R&D efforts will be boosted by South Korea’s advanced medical and research infrastructure, combined with the growing biotechnology industry in the forecasted period. Low levels of early diagnosis, lack of a regular screening program are the factors that impede the growth of the market.

1. South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview…………………….
A. Market Size
2. Market Growth Drivers………………………………………….
A. Increasing Incidence of NSCLC
B. FDAs Accelerated Approval System
3. Types Of Non-Small Cell Lung Cancer (NSCLC)……………………………………….
A. Adenocarcinoma
B. Squamous Cell Carcinoma
C. Large Cell Carcinoma
4. Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Segmentation……
A. Therapy
I. Targeted Therapy
II. Immunotherapy
III. Chemotherapy
B. Drug Class
I. Angiogenesis Inhibitors
II. Kinase Inhibitors
III. Epidermal Growth Factor Receptor Blockers
IV. Microtubule Stabilizers
V. PD-1/PD-L1 Inhibitors
VI. Folate Antagonists
5. Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Share…………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………….
A. Yuhan Company Overview, Product & Services, Strategies & Financials
B. AstraZeneca Korea Company Overview, Product & Services, Strategies & Financials
C. Boehringer Ingelheim Company Overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………
A. New Trends and Development of Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market
B. Future Opportunities
10. Conclusion


Market Segmentation

By Therapy:

According to the type of therapy used in treating NSCLC, market is segmented into targeted therapy, immunotherapy, and chemotherapy.

By Drug Class:

According to the class of drugs market is segmented into angiogenesis inhibitors, kinase inhibitors, epidermal growth factor receptor blockers, microtubule stabilizers, PD-1/PD-L1 inhibitors, and folate antagonists. Angiogenesis inhibitors were the most in demand in the non-small cell lung cancer treatment market due to the high efficacy of the drug.


Top Players

Affluent players in the NSCLC domestic market are AstraZeneca Korea, Boehringer Ingelheim, Yuhan Corporation, Eli Lilly, Bristol Myers Squibb Company, Novartis, F. Hoffmann-La Roche, Janssen Pharmaceuticals, Ono Pharmaceuticals, Takeda Pharmaceuticals Korea, and others.

In January 2021, South Korea’s health authorities granted marketing authorization to Yuhan Corp.’s Leclaza (lazertinib mesylate monohydrate) for the treatment of patients with non-small cell lung cancer (NSCLC).

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements